Physician profile

He Zhang

Pulmonary Disease · Waterbury, CT

NPI 1154593226

$1,524.99

in general payments reported to CMS, 2019-2025

18 companies · $136 in 2025

The $136 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$583.86
Education$89.99

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Glaxosmithkline, LLC. $784.70 2019-2025 Nucala, Trelegy Ellipta, Arexvy
Boehringer Ingelheim Pharmaceuticals, INC. $167.67 2019
Sanofi-Aventis U.S. LLC $89.99 2024
Astrazeneca Pharmaceuticals Lp $58.45 2019
Takeda Pharmaceuticals U.S.A., INC. $53.24 2023-2024 Glassia
Csl Behring $51.76 2020-2022
Zoll Respicardia, INC. $47.91 2024 Remede System
Amgen INC. $37.93 2024-2025 Tezspire
Circassia INC. $33.14 2019-2020
3b Medical, INC. $29.94 2025 Luna
Insmed, INC. $29.32 2019-2025 Arikayce
Baxter Healthcare $26.20 2023 Hillrom - Life 2000 Ventilation System
Shire North American Group INC $24.06 2019
Grifols USA, LLC $20.45 2019
Genzyme Corporation $19.46 2020
Show all 18 companies
CompanyGeneral paymentsYearsTop products
Pulmonx Corporation $17.43 2022
Regeneron Healthcare Solutions, INC. $17.34 2019
Jazz Pharmaceuticals INC. $16.00 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

He Zhang

$1,524.99

in general payments reported 2019-2025

Years
2019-2025
Top company
Glaxosmithkline, LLC.
Context
The $136 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/98321/he-zhang

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.